NDAINJECTIONINJECTABLE
Approved
Feb 1996
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
1
Data completeness
2/8 — Basic
Drug data last refreshed 1h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
DEXFERRUM (iron dextran) is an intravenous iron replacement therapy indicated for patients with iron deficiency anemia who cannot tolerate or absorb oral iron supplementation. It works by delivering elemental iron directly into the bloodstream, bypassing gastrointestinal absorption limitations. This product serves patients with chronic kidney disease, heavy menstrual bleeding, and post-surgical anemia.
LOE Approaching
As a mature product approaching loss of exclusivity with moderate competitive pressure (30%), the brand team is likely focused on retention and lifecycle management rather than expansion.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (1)
Intravaneous Iron(1000 mg Low Molecular Weight Iron Dextran Over 60 Minutes) for Pregnant Women
Started Jul 2013
74 enrolled
Pregnancy
Career Relevance
Working on DEXFERRUM offers career experience in mature product management, generic defense strategy, and market access within a stable but competitive therapeutic area. This role is ideal for professionals seeking to develop expertise in lifecycle management, managed care negotiations, and customer retention in the specialty injectable space.
Brand Manager
Worked on DEXFERRUM at AbbVie? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.